...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM - High Level Summary

fouremm, thanks, that's good news. Your posts today have added quite a bit of clarity to this short-on-info split. It sounds better than I had feared.

Share
New Message
Please login to post a reply